profiling deep minimal residual disease in multiple myeloma
Published 3 years ago • 73 plays • Length 2:51Download video MP4
Download video MP3
Similar videos
-
3:19
what impact have new minimal residual disease (mrd) assessment techniques had in myeloma?
-
3:22
the main prognostic factors and why minimal residual disease is becoming crucial in multiple myeloma
-
2:23
the use of immunophenotyping to assess minimal residual disease (mrd) in multiple myeloma
-
0:34
medical animation: multiple myeloma minimal residual disease (mrd)
-
11:23
challenges and future perspectives for minimal residual disease (mrd) in multiple myeloma
-
1:04:29
level up immune profiling of the tumor microenvironment - deep phenotyping and target discovery
-
10:03
an overview of comprehensive genomic profiling
-
49:36
experience with mm mrd in our clinical laboratory: theory and practice
-
1:39
minimal residual disease (mrd) monitoring for multiple myeloma is here to stay
-
2:12
gene expression profiling in multiple myeloma
-
2:05
multiomics profiling of mrd to understand the biology of drug resistance in multiple myeloma
-
3:40
what’s new in minimal residual disease (mrd) detection in myeloma?
-
3:36
minimal residue disease (mrd) in multiple myeloma
-
4:05
are we ready to use minimal residual disease (mrd) to direct multiple myeloma therapy?
-
1:26
mrd in myeloma: the fda perspective
-
1:07
mrd-guided treatment in multiple myeloma
-
2:55
multiple myeloma mrd assessment
-
19:41
multiple myeloma: minimal residual disease
-
3:58
what role will minimal residual disease testing play in multiple myeloma?
-
1:57
using molecular abnormalities for risk stratification in multiple myeloma at the time of diagnosis
-
2:36
a multi-omic study to improve the diagnosis of multiple myeloma
-
0:58
minimumm-seq: a novel, minimally invasive approach to characterize myeloma pathology